Global Non-Invasive Prenatal Testing Market is estimated to value over USD 6 billion by 2026 end and register a CAGR of over 12.8% during the forecast period 2019 to 2026.

Highly risky chromosomal abnormalities, improving reimbursement scenario for NIPT coupled with growing awareness regarding NIPT, and rising preference for non-invasive techniques are factors responsible for the non-invasive prenatal testing market growth.
Nonetheless, societal and ethical restrictions and a lack of skilled professionals is restraining the non-invasive prenatal testing market growth. The Asia Pacific region is an untapped market space and has immense growth opportunities in the near future.
Trisomy Applications Segment is Anticipated to Dominate the Global Market Over the Forecast Period
Trisomy has the largest non-invasive prenatal testing market share in 2018 and it is predicted to grow significantly over the forecast period. Furthermore, this segment is estimated to grow at the highest CAGR over the forecast period. The high growth and large share of this segment can be primarily attributed to factors such as the rising incidence of chromosomal abnormalities and increasing maternal age.
Regionally, the non-invasive prenatal testing market is bifurcated into North America, Europe, Asia, and the rest of the world. North America accounted for the largest non-invasive prenatal testing market share, followed by Europe. Additionally, the Asia Pacific is projected to proliferate at the highest CAGR over the forecast period. Rising conferences and awareness programs, increasing focus of prominent players on expanding their presence in Asia and the developing healthcare infrastructure are driving the non-invasive prenatal testing market growth in the region.
Key market players include Illumina Inc., Thermo Fisher Scientific Inc., GE Healthcare, Perkinelmer Inc., Agilent Technologies Inc., Beijing Genomics Institute, F. Hoffmann-La Roche Ltd., Laboratory Corp. of America Holdings, Natera Inc. and Yourgene Health.

Illumina Inc., one of the biggest names in this market, offers support services, NIPT, genotyping and whole-genome sequencing which further strengthen its market position.
For the last three years, Illumina has launched multiple products to sustain its leading position in the non-invasive prenatal testing market. The company has invested a huge amount of its revenue on research and development expenditure. In 2018, Illumina invested over 18% of its revenue on research and development. Illumina expanded its non-invasive prenatal testing market size with the launch of VeriSeq NIPT Solution v2 in January 2019.
The company also focuses on inert strategies with leading market players to strengthen its research & commercialization capabilities and develop advanced technologies. Illumina is projected to witness high non-invasive prenatal testing market growth over the forecast period, due to its strong product innovation capabilities, product portfolio, and wide regional presence.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3411&...
Global Non-Invasive Prenatal Testing Market Segmentation:
By Product & Service
• Products
a. Consumables
•
o Assay Kits & Reagents
o Disposables
b. Instruments
 Ultrasound Devices
 Next-Generation Sequencing Systems
 Polymerase Chain Reaction Instruments
 Microarrays
 Other Instruments
o Services
By Method
• Ultrasound Detection
• Biochemical Screening Tests
• Cell-Free DNA in Maternal Plasma Tests
By Application
• Trisomy
• Microdeletion Syndrome
• Other Applications
By End User
• Diagnostic Laboratories
• Hospitals
By Region
• North America
• Europe
• Asia Pacific
• Rest of the World
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3411&...
Competitive Landscape:
● Qualifacts Systems in 2017 introduced a software solution for mobile behavioral health. The software aims to provide fully functional mobile applications for the staff of behavioral healthcare
● Medicare introduced diagnostic codes for reimbursement of tele-mental healthcare services in 39 US states
FutureWise Key Takeaways
● Growth Prospects
● SWOT Analysis
● Key Trends
● Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global behavioural health market by component, by delivery model, by function, by end-user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• Evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and core competencies
FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global non-invasive prenatal testing market by product & service, by method, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe and rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Table of Contents
Chapter 1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
Chapter 2 Research Methodology
2.1 Research Data
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
Chapter 3 Executive Summary
Chapter 4 Niche Insights
4.1 Non-Invasive Prenatal Testing: Market Overview
4.2 Non-Invasive Prenatal Testing Market, By Application (2019–2026)
4.3 Non-Invasive Prenatal Testing Market Share, By Method & Region (2018)
4.4 Non-Invasive Prenatal Testing Market: Geographic Growth Opportunities
Chapter 5 Market Overview
5.1 Introduction
5.1.1 Drivers
5.1.1.1 High Risk of Chromosomal Abnormalities With Increasing Maternal Age
5.1.1.2 Growing Preference for Noninvasive Techniques Over Invasive Methods
5.1.1.3 Improving Reimbursement Scenario for NIPT
5.1.1.4 Programs Focusing on Increasing the Awareness of NIPT
5.1.2 Opportunities
5.1.2.1 Untapped Emerging Markets
5.1.3 Challenges
5.1.3.1 Reliability of Test Results, Especially in Obese Women
5.1.3.2 Lack of Skilled Professionals
Chapter 6 Non-Invasive Prenatal Testing Market, By Product & Service
6.1 Introduction
6.2 Products
6.2.1 Consumables
6.2.1.1 Assay Kits & Reagents
6.2.1.1.1 North America is the Largest Market for Assay Kits & Reagents Segments
6.2.1.2 Disposables
6.2.1.2.1 Use of Disposables to Avoid Contamination is One of the Major Growth Factors for This Segment
6.2.2 Instruments
6.2.2.1 Ultrasound Devices
6.2.2.1.1 Popularity of Ultrasound in Fetal and Embryonic Imaging and Safety has Driven Market Growth
6.2.2.2 Next-Generation Sequencing Systems
6.2.2.2.1 Ngs Systems have Found Rising Use in NIPT
6.2.2.3 Polymerase Chain Reaction Instruments
6.2.2.3.1 Increasing Research in the Field of Prenatal Genetic Testing is Expected to Boost Market Growth
6.2.2.4 Microarrays
6.2.2.4.1 Flexibility of Chips and Short Processing Times have Supported the Use of Microarrays
6.2.2.5 Other Instruments
6.3 Services
6.3.1 North America Shows the Highest Demand for Testing Services
Chapter 7 Non-Invasive Prenatal Testing Products Market, By Method
7.1 Introduction
7.2 Ultrasound Detection
7.2.1 Ultrasound Detection Segment Dominates the NIPT Products Market
7.3 Biochemical Screening Tests
7.3.1 High Incidence of Genetic Disorders & Increasing Focus on Prenatal Testing to Support Market Growth
7.4 Cell-Free Dna in Maternal Plasma Tests
7.4.1 Cell-Free Dna in Maternal Plasma Tests Segment to Register the Highest CAGR in the Forecast Period
8 Non-Invasive Prenatal Testing Market, By Application (Page No. - 61)
8.1 Introduction
8.2 Trisomy
8.2.1 Trisomy Forms the Largest and Fastest-Growing Application Segment of the NIPT Market
8.3 Microdeletion Syndrome
8.3.1 High Incidence of Microdeletion Syndrome is A Key Factor Driving the Growth of This Application Segment
8.4 Other Applications
Chapter 9 Non-Invasive Prenatal Testing Products Market, By End User
9.1 Introduction
9.2 Diagnostic Laboratories
9.2.1 Increase in Research Intensity to Drive the Usage of NIPT Products Among Diagnostic Labs
9.3 Hospitals
9.3.1 North America Holds the Major Share of This End-User Segment
Chapter 10 Non-Invasive Prenatal Testing Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 High Number of Babies Born With Chromosomal Syndromes is A Major Factor Driving the Demand for Non-Invasive Prenatal Testing in the US
10.2.2 Canada
10.2.2.1 Unfavorable Reimbursement Scenario for Non-Invasive Prenatal Testing is A Key Challenge for Market Growth in Canada
10.3 Europe
10.3.1 France
10.3.1.1 Favorable Insurance Coverage for Prenatal Testing to Increase the Adoption of NIPT in France
10.3.2 UK
10.3.2.1 High Incidence of Genetic Abnormalities to Increase the Demand for Prenatal Testing Procedures in the UK
10.3.3 Germany
10.3.3.1 Increasing Healthcare Spending—A Major Factor Contributing to Market Growth in Germany
10.3.4 Rest of Europe
10.4 Asia
10.4.1 High Cost of NIPT Products is A Major Factor Limiting Market Growth in Asia During the Forecast Period
10.5 Rest of the World
Chapter 11 Competitive Landscape
11.1 Overview
11.2 Market Player Ranking
11.3 Competitive Leadership Mapping – Product Market
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Dynamic Differentiators
11.3.4 Emerging Players
11.4 Competitive Situation and Trends
11.4.1 Product & Services Launches
11.4.2 Expansions
11.4.3 Acquisitions
11.4.4 Other Strategies
Chapter 12 Company Profile
(Business Overview, Products and Services Offered, Recent Developments, and FutureWise Perspective)*
12.1 Illumina, Inc.
12.2 Thermo Fisher Scientific, Inc.
12.3 GE Healthcare (A Wholly Owned Subsidiary of General Electric Company)
12.4 Perkinelmer, Inc.
12.5 Agilent Technologies, Inc.
12.6 Beijing Genomics Institute
12.7 F. Hoffman-La Roche Ltd.
12.8 Laboratory Corporation of America Holdings
12.9 Natera, Inc.
12.10 Yourgene Health

Chapter 13 Research Finding and Conclusion

Chapter 14 Research Methodology

Chapter 15 Research Data Source

Inquire further details about this report at: [email protected]

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com